Table 1 Review of cases of choroidal sarcoid granuloma
From: Choroidal sarcoid granuloma: a case report and review of the literature
Year | Author | Sex | Age (yrs.) | Race | Eye | Presenting Symptoms | F/U (mo.) | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|
2010 | Verma et al. [15] | M | 46 | N/A | OD | Painless, gradual loss of vision in the right eye with floaters for 20 days | 1 | Systemic steroids | Reduction in mass size Improvement in visual acuity (VA) |
2020 | Ung et al. [16] | M | 55 | N/A | OU | Asymptomatic | 12 | No treatment Tapering of Nivolumab | Stabilization in the size of the mass |
1982 | Marcus et al. [17] | F | 19 | African American | OD | Blurred vision in the right eye for 2 months | 6 | Systemic steroids | Resolution of mass VA of 20/20 |
1982 | Marcus et al. [17] | F | 31 | African American | OD | Decreased vision in the right eye for 1 week with right sided headaches | 12 | Systemic steroids | Resolution of mass VA of 20/20 |
2009 | Doycheva et al. [18] | F | 49 | N/A | OU | Visual disturbances for 2 months | 48 | Systemic and topical steroids Tapering of INF-a | Resolution of mass Improvement of VA |
2009 | Doycheva et al. [18] | M | 37 | N/A | OU | Floaters and decreased vision | 60 | Topical steroids Tapering of INF-a | Resolution of mass VA of 20/20 |
2009 | Doycheva et al. [18] | F | 65 | N/A | OS | Visual disturbances and floaters for 8 days | 72 | Topical steroids Tapering of INF-a | Resolution of mass VA of 20/20 |
2017 | Turkoglu et al. [19] | M | 66 | N/A | OS | Asymptomatic | 2 | Systemic steroids | Resolution of mass |
2020 | Schönbach et al. [20] | M | 67 | African American | OD | Progressive decreased vision and floaters in the right eye | 3.5 | Topical Cyclopentolate and steroids Triamcinolone Injection Systemic steroids | Resolution of mass VA of 20/20 |
2021 | Pichi et al. [21] | F | 10 | Caucasian / Middle Eastern | OD | Blurry vision in the right eye | N/A | Afilbercept Systemic steroids | Initially worsened with Afilbercept but improved after steroids Resolution of mass Improvement of VA |
2017 | Stefater et al. [22] | F | 55 | N/A | OD | Asymptomatic | 216 | N/A | Gradual increase in mass size over time with development of smaller lesions VA of 20/20 |
2018 | Knickelbein et al. [23] | F | 25 | African American | OS | Bilateral red sore eyes for 3 months Decreased vision in the left eye for 2 months | 30 | Systemic steroids Cyclosporine Mycophenolate Infliximab | Resolution of mass Improvement of VA |
2021 | Armbrust et al. [24] | M | 54 | Caucasian | OD | Blurry vision in the right eye over 2–3 months | 12 | Systemic steroids Adalimumab | Residual lesion present |
2013 | Chen et al. [25] | M | 50 | N/A | OU | Vision loss with floaters in the right eye for 3 years Decreased vision in the left eye for 11 months | 6 | Combination steroid and immunosuppressive drugs | Improvement observed |
2017 | Ishihara et al. [26] | M | 38 | Asian | OD | Blurry vision in the right eye | 6 | Systemic steroids Triamcinolone injection | Resolution of mass |
2021 | Kita et al. [27] | M | 36 | Asian | OS | Asymptomatic | N/A | Triamcinolone injection | Resolution of mass VA of 20/20 |
1983 | Olk et al. [28] | F | 25 | Caucasian | OS | Central blurring in the left eye for 3 days | 12 | Systemic steroids | Resolution of mass VA of 20/20 |
2021 | Kobayashi et al. [29] | M | 38 | Asian | OS | Decreased visual acuity in the left eye | 12 | Systemic steroids Triamcinolone injection | Reduction in mass size Improvement of VA |
2014 | Khatib et al. [30] | F | 52 | N/A | OS | Asymptomatic | 5 | Triamcinolone injection | Resolution of mass VA of 20/20 |
2013 | Kumar et al. [31] | F | 35 | N/A | OD | Painless decreased vision in the right eye | 8 | Triamcinolone injection Topical steroids | Resolution of mass Improvement of VA |
2017 | Pandya et al. [32] | M | 30 | Caucasian / Middle Eastern | OU | Progressively worsening headaches for 6 weeks with a 2-week history of bilateral ocular pain, redness, photophobia, and blurred vision | N/A | Systemic steroids Methotrexate Mycophenolate Infliximab Triamcinolone injection | VA of 20/20 Patient required bilateral Trabeculectomy for elevated IOP |
2005 | Chan et al. [33] | M | 29 | Asian | OS | Left paracentral visual field loss for 2 weeks | 48 | Systemic steroids Triamcinolone injection | Reduction in mass size Improvement of VA |
2013 | Modi et al. [34] | F | 63 | African American | OD | Painless decrease in vision of the right eye with metamorphopsia for 3 months | 12 | Systemic steroids | Resolution of mass Improvement of VA |
1992 | Tingey et al. [35] | M | 26 | Caucasian | OS | Blurred vision in the left eye for 8 weeks | 13 | Systemic steroids | Resolution of mass Worsening of VA |
1984 | Campo et al. [36] | M | 33 | African American | OD | Two months of blurred vision in the right eye | 10 | Systemic steroids | Resolution of mass Improvement of VA |
1984 | Campo et al. [36] | F | 62 | Caucasian | OS | Blurred vision in the left eye for 1 week | 8 | Systemic steroids | Reduction in mass size Improvement of VA |
2022 | Hage et al | F | 45 | Caucasian /Middle Eastern | OD | Asymptomatic | 9 | Systemic steroids | Resolution of mass Worsening of VA compared to baseline |